Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Sees Large Decline in Short Interest

Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) saw a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 600 shares, a decline of 60.0% from the January 31st total of 1,500 shares. Based on an average daily trading volume, of 16,500 shares, the days-to-cover ratio is presently 0.0 days.

Institutional Investors Weigh In On Tema Cardiovascular and Metabolics ETF

An institutional investor recently raised its position in Tema Cardiovascular and Metabolics ETF stock. Sterling Investment Advisors Ltd. lifted its holdings in Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 5.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 167,703 shares of the company’s stock after buying an additional 9,008 shares during the quarter. Tema Cardiovascular and Metabolics ETF accounts for 1.2% of Sterling Investment Advisors Ltd.’s portfolio, making the stock its 24th biggest holding. Sterling Investment Advisors Ltd. owned 7.29% of Tema Cardiovascular and Metabolics ETF worth $4,842,000 as of its most recent SEC filing.

Tema Cardiovascular and Metabolics ETF Price Performance

Shares of HRTS stock traded up $0.34 during mid-day trading on Friday, hitting $30.78. The stock had a trading volume of 15,828 shares, compared to its average volume of 14,070. The firm has a market cap of $70.79 million, a PE ratio of 32.89 and a beta of 0.93. The company’s 50-day simple moving average is $29.82 and its 200-day simple moving average is $32.04. Tema Cardiovascular and Metabolics ETF has a fifty-two week low of $28.56 and a fifty-two week high of $36.03.

Tema Cardiovascular and Metabolics ETF Dividend Announcement

The company also recently disclosed a dividend, which was paid on Thursday, December 12th. Investors of record on Wednesday, December 11th were given a $0.4693 dividend. The ex-dividend date of this dividend was Wednesday, December 11th.

Tema Cardiovascular and Metabolics ETF Company Profile

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.